We’re making GPT-5 warmer and friendlier based on feedback that it felt too formal before. Changes are subtle, but ChatGPT should feel more approachable now.
You'll notice small, genuine touches like “Good question” or “Great start,” not flattery. Internal tests show no rise in sycophancy compared to the previous GPT-5 personality.
Changes may take up to a day to roll out, more updates soon.
As shown in the livestream, Plus and Pro users globally can now connect Gmail and Google Calendar to ChatGPT for more useful, relevant responses in chat.
Recapping the updates we’ve made to ChatGPT in the past week:
- GPT-4o available under “Legacy models” by default for paid users
- Paid users can toggle on “Show additional models” in settings to add legacy models like o3 and GPT-4.1, as well as GPT-5 Thinking mini, to the model picker
- GPT-5 includes Auto, Fast, and Thinking in the model picker. Fast gives faster answers, Thinking takes more time to give deeper answers, Auto routes between Fast and Thinking
Plus & Team users now get up to 3,000 messages/week on GPT-5 Thinking, with extra capacity on GPT-5 Thinking mini when limit is hit
-GPT-5 now available for Enterprise & Edu users
Coming soon: A warmer, more familiar personality for GPT-5.
Transforming drug discovery with AI! 🌟 Accutar Biotechnology harnesses advanced artificial intelligence to revolutionize the way new medicines are developed, combining computational design with lab validation to bring treatments faster and more cost-effectively.
At Accutar Biotech, we're revolutionizing the way medicines are developed. Our cutting-edge approach harnesses artificial intelligence to decode the physical and chemical nature of biological systems, accelerating the path from concept to cure.
—
At Accutar Biotech, we’re unlocking new possibilities in medicine with AI-powered drug discovery and bioinformatics. Our innovative teams push boundaries to deliver hope and transformative therapies for patients everywhere. Experience the future with us! #BioTech#AI
Shaping the future of healthcare, Accutar Biotech empowers drug discovery with visionary AI technologies. Our commitment: faster breakthroughs and smarter solutions for patients worldwide. Join us on our journey to redefine what’s possible in biotech! #AIforHealth
Pioneering AI-driven solutions at Accutar Biotech, revolutionizing drug discovery with precision and speed. Our hybrid approach merges computational design with wet lab validation to develop breakthrough therapies faster and more cost-effectively.
Harnessing the power of #AI to transform drug discovery. At Accutar Biotech, we combine computational design with wet lab validation to accelerate innovative therapies and reduce development time and cost. Be transformative. For patients. #Biotech
"Accelerating drug discovery with AI at Accutar Biotechnology! 💡 Our innovative AI-powered platform is transforming how targeted therapies are designed and developed, bringing hope to patients faster than ever. Follow us for the latest breakthroughs in biotech and medicine.